Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
OPERATING ACTIVITIES
Net income (loss)	$ 24.6	$ 43.4
Reconciliation to net cash provided by (used for) operating activities:
Depreciation and amortization	24.9	25.0
Equity in earnings of unconsolidated affiliate	(4.1)	(5.4)
Costs related to legacy matters	46.9	2.0
Cash paid for legacy matters	3.2	6.3
Provision for (benefit from) income taxes	10.9	24.8
Cash paid for income taxes	(10.9)	(8.9)
Income tax refunds received	0.8	0.0
Interest expense and related financing costs	20.0	19.3
Cash paid for interest	(6.5)	(5.3)
Defined benefit pension expense	4.8	3.8
Cash paid under defined benefit pension arrangements	(4.0)	(3.7)
Changes in assets and liabilities, excluding effect of currency translation and acquisitions:
Trade accounts receivable	26.6	20.1
Inventories	(35.5)	(23.0)
Accounts payable	3.5	10.5
All other items, net	(27.8)	(7.3)
Net cash provided by (used for) operating activities	71.0	89.0
INVESTING ACTIVITIES
Capital expenditures	(38.2)	(50.1)
Other investing activities	(7.9)	1.6
Net cash provided by (used for) investing activities	(46.1)	(48.5)
FINANCING ACTIVITIES
Borrowings under credit arrangements	2.2	8.6
Repayments under credit arrangements	(5.7)	(11.7)
Cash paid for repurchases of common stock	(4.8)	(35.0)
Proceeds from exercise of stock options	9.2	0.8
Dividends paid to shareholders	(18.4)	(16.2)
Other financing activities	(4.3)	(1.6)
Net cash provided by (used for) financing activities	(21.8)	(55.1)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash	(0.3)	2.4
Net increase (decrease) in cash and cash equivalents	2.8	(12.2)
Cash, cash equivalents, and restricted cash, beginning of period	201.0	163.5	$ 163.5
Cash, cash equivalents, and restricted cash, end of period	203.8	151.3	$ 201.0
Supplemental disclosure of cash flow information
Capital expenditures in accounts payable	$ 44.3	$ 29.6